معرفی
Dr. Daohong Lin serves as an Assistant Professor in the Department of Pharmacology at New York Medical College's School of Medicine, where she leads NIH-funded research on renal potassium channel regulation. Her work bridges molecular physiology and clinical implications for electrolyte disorders.
Education:
- M.D. in Clinical Medicine from Harbin Medical University
- Ph.D. in Pharmacology from Harbin Medical University/New York Medical College
- M.S. in Microbiology from Harbin Medical University
Research Focus: Dr. Lin's laboratory investigates inwardly rectifying potassium channels (Kir) in renal epithelial cells, specializing in ROMK (Kir1.1) and Kir4.1/Kir5.1 heteromers. Her team employs molecular biology, protein chemistry, and electrophysiology to dissect mechanisms involving protein kinases, ubiquitination, and microRNA in dietary potassium regulation. Current projects examine calcineurin/mTOR signaling pathways and their roles in potassium excretion disorders.
Publication Trends: Recent works (2022-2024) reveal expanding investigation into Kir channel interactions with sodium transporters and immunosuppressant effects. Her studies consistently connect molecular mechanisms to clinical conditions like hyperkalemia and hypokalemia, with increasing emphasis on therapeutic targets for electrolyte imbalances.
Scientific Recognition:
- American Heart Association Scientific Development Grant (2011)
Research Support & Mentorship: Principal Investigator for NIH R01 grants (2017, 2023) studying Kir5.1 regulation. Contributes to graduate pharmacology education through PSE curriculum instruction while mentoring junior researchers in renal physiology techniques. Editorial roles with American Journal of Physiology-Renal Physiology and Frontiers in Physiology demonstrate peer recognition.
Professional Engagement: Active member of the American Physiological Society with ongoing collaborations in renal transport mechanisms research.
